Cart
0

Syphilis Testing Market by Types (Primary Syphilis, Secondary Syphilis) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

Get 20% Free Customization In This Report
LI_15675
Pages: 118
May 2015 | 1985 Views
 
Author's : Garima Chandra
Tables: 66
Charts: 37
 

Syphilis Testing Market Overview:

Global Syphilis Testing Market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the forecast period 2015-2020.

Get more information on this report : Request Sample Pages

Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately.

Syphilis continues to be a global health concern due to the increasing incidences occurring mainly among bisexuals and gay people. According to the World Health Organization (WHO), there were an estimated 36 million cases of syphilis in 2013 globally, with over 11 million new cases occurring annually. Additionally, around 90% of the syphilis cases are prevalent in developing countries with similar trends now observed in developed nations as well. The increasing syphilis cases are mainly due to the growing rate of anonymous sex, sex with multiple partners, sex under the influence of several drugs and increasing number of unprotected sex both anal and oral. Moreover, this is also gaining prominence in pregnant women due to the sex with infected partners, which can further lead to congenital abnormalities such as stillbirth, abortions and other abnormalities in pregnancy.

There are various methods used for diagnosing syphilis cases, which include venereal disease research laboratory (VDRL) test, rapid plasma reagin (RPR) test, enzyme immunoassay (EIA) test and few others. All syphilis tests are serological i.e. based upon antibodies present in the body fluid. The market would continue to grow primarily due to the rising incidences of fatal syphilis diseases, disease-related high-economic burden and concurrent implementation of new programs such as provider-initiated counselling and testing (PICT) and client-initiated counselling and testing (CICT). However, inadequate infrastructure provisions such as labs, equipment and supplies, lack of trained laboratory personnel in secluded geographic locations such as West African countries and the stigma associated with voluntary testing are likely to be some of the major restraints of the market.

The report segments the global market for syphilis testing on the basis of type and geography. Based on type, the market is segment into primary and secondary syphilis testing. Geographically, the market is segmented into North America, Europe, Asia Pacific and LAMEA. LAMEA and Asia Pacific region account for majority of the syphilis testing market and collectively accounted for 4/5th share of the global market value in 2014. Higher adoption rates for technologically advanced screening tests, active measures from the governments and private associations along with the growing awareness for the syphilis infections largely contribute to growth of the market in the aforesaid regions. The major players are focusing on technological advancements in developing syphilis testing products along with complementary service portfolios. Some of the key companies profiled in the report are Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.

Syphilis Testing Market Key Market Benefits

  • This report provides an extensive analysis of the current and emerging market trends along with the market dynamics of the global market

  • A comprehensive analysis of types and geography segments helps to identify the growth opportunities 

  • Competitive intelligence (of leading manufacturers and distributors of leading syphilis testing devices and services) highlights the business practices followed by leading market players across the geographies

  • The projections in the report are made by analyzing the current market trends and market potential for the period of 2014-2020, in terms of value and volume

  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

Syphilis Testing Market Key Market Segments

The global market is segmented into types and geography.

 By Types - 

  • Primary Syphilis

  • Secondary Syphilis

 By Geography -

  • North America

    • United States

    • Canada

    • Mexico

  • Europe

    • U.K.

    • Germany

    • Spain

    • Greece

    • Belgium

    • Moldova

    • Rest of Europe

  • Asia-Pacific

    • Australia

    • Japan

    • India

    • China

    • Rest of Asia Pacific

  • LAMEA

    • Latin America

    • Middle East

    • Africa

 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.1 Research methodology

1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Upcoming trends for Syphilis diagnostic testing market

3.2.1 Executing and ensuring accreditation for the qualification of participants in National Screening Programs around the globe.
3.2.2 Technological Advancements for Syphilis diagnostic testing market

3.3 Syphilis diagnostic tests
3.4 Key Findings

3.4.1 Top Factors Impacting global Syphilis diagnostic testing market
3.4.2 Top Investment Pockets of global Syphilis diagnostic testing market (2014-2020)
3.4.3 Top winning strategies of global Syphilis diagnostic testing market

3.5 Government Regulations and reimbursement scenario

3.5.1 Government Regulation
3.5.2 Reimbursement policies for Syphilis testing

3.6 Value Chain Analysis

3.6.1 Primary Activities
3.6.2 Supportive Activities

3.7 Market dynamics

3.7.1 Drivers

3.7.1.1 Growing incidence rates and increasing prevalence rates of Syphilis
3.7.1.2 Implementation of National Screening Programs
3.7.1.3 Supporting Reimbursement for Syphilis testing

3.7.2 Restraints

3.7.2.1 Social stigma associated with patients visiting specialized STD clinics.
3.7.2.2 Huge proportion of patients infected with Syphilis in remote areas.
3.7.2.3 Stringent regulatory abidance requirements for the participants of Syphilis market

3.7.3 Opportunities

3.7.3.1 Decreasing number of visits to GUM clinics and specialized STD clinics
3.7.3.2 National screening Programs across the globe
3.7.3.3 Niche opportunities for technology and POC test providers in an emerging economies

Chapter: 4 GLOBAL SYPHILIS TESTING MARKET, BY TYPE, 2014-2020

4.1 P&S Syphilis testing (volume and value)

4.1.1 Key market trends
4.1.2 Market size and forecast, (volume & value)

4.1.2.1 Global Testing Market for Syphilis,value, ($million)
4.1.2.2 Global Testing Market for Syphilis, volume, (million)

4.2 Primary Syphilis
4.3 Secondary Syphilis

4.3.1 Market size and forecast, (volume & value)

Chapter: 5 GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020

5.1 North America

5.1.1 Market size and forecast, (volume & value)
5.1.2 U.S.

5.1.2.1 Market size and forecast (Volume & Value)

5.1.3 Mexico

5.1.3.1 Market size and forecast, (volume & value)

5.1.4 Canada

5.1.4.1 Market size and forecast, (volume & value)

5.2 Europe

5.2.1 Market size and forecast, (volume & value)
5.2.2 Spain

5.2.2.1 Market size and forecast, (volume & value)

5.2.3 Greece

5.2.3.1 Market size and forecast, (volume & value)

5.2.4 Belgium

5.2.4.1 Market size and forecast, (volume & value)

5.2.5 Germany

5.2.5.1 Market size and forecast, (volume & value)

5.2.6 Moldova

5.2.6.1 Market size and forecast, (volume & value)

5.2.7 United Kingdom

5.2.7.1 Market size and forecast, (volume & value)

5.2.8 Rest of Europe

5.2.8.1 Market size and forecast, (volume & value)

5.3 Asia Pacific

5.3.1 Market size and forecast, (volume & value)
5.3.2 India

5.3.2.1 Market size and forecast, (volume & value)

5.3.3 China

5.3.3.1 Market size and forecast, (volume & value)

5.3.4 Japan

5.3.4.1 Market size and forecast, (volume & value)

5.3.5 Australia

5.3.5.1 Market size and forecast, (volume & value)

5.3.6 Rest of Asia-Pacific

5.3.6.1 Market size and forecast, (volume & value)

5.4 LAMEA

5.4.1 Market size and forecast, (volume & value)
5.4.2 Latin America

5.4.2.1 Market size and forecast, (volume & value)
5.4.2.2 Argentina

5.4.2.2.1 MARKET SIZE AND FORECAST, (VOLUME & VALUE)

5.4.3 Middle East

5.4.3.1 Market size and forecast, (volume & value)

5.4.4 Africa

5.4.4.1 Market size and forecast, (volume & value)

Chapter: 6 COMPANY PROFILES

6.1 Roche Diagnostics

6.1.1 Company overview
6.1.2 Roche Diagnostics company snapshot
6.1.3 Operating business segments
6.1.4 Financial performance
6.1.5 Strategic moves and developments
6.1.6 SWOT analysis Roche Diagnostics

6.2 BioMerieux

6.2.1 Company overview
6.2.2 Biomerieux Company Snapshot
6.2.3 Operating business segments
6.2.4 Business performance
6.2.5 SWOT analysis of BioMerieux

6.3 Hologic, Inc.

6.3.1 Company overview
6.3.2 Hologic, Inc. Company Snapshot
6.3.3 Operating business segments
6.3.4 Financial performance
6.3.5 Strategic moves and developments
6.3.6 SWOT analysis of Hologic Inc

6.4 Becton Dickinson And Company

6.4.1 Company overview
6.4.2 Becton Dickinson And Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business performance
6.4.5 Key Strategies and development
6.4.6 SWOT analysis of Becton Dickinson and Company

6.5 Cepheid Inc.

6.5.1 Company overview
6.5.2 Cephide Inc. company snapshot
6.5.3 Operating Business Segments
6.5.4 Financial performance
6.5.5 Strategic moves and developments
6.5.6 SWOT analysis of Cepheid Inc.

6.6 Danaher Corporation

6.6.1 Company overview
6.6.2 Danaher Corporation Company Snapshot
6.6.3 Operating business segments
6.6.4 Business performance
6.6.5 Key Strategies and development
6.6.6 SWOT analysis of Danaher Corporation

6.7 Affymetrix, Inc.

6.7.1 Company overview
6.7.2 Affymetrix Inc. Company Snapshot
6.7.3 Operating. business segments
6.7.4 Financial performance
6.7.5 SWOT analysis of Affymetrix Inc

6.8 Alere Inc.

6.8.1 Company overview
6.8.2 Alere Inc. Company Snapshot
6.8.3 Operating business segments
6.8.4 Business performance
6.8.5 Key Strategies and developments
6.8.6 SWOT analysis of Alere Inc.

6.9 Abbott Laboratories

6.9.1 Company overview
6.9.2 Abbott Laboratories company snapshot
6.9.3 Operating business segments
6.9.4 Financial performance
6.9.5 Strategic moves and developments
6.9.6 SWOT analysis of Abbott Laboratories

6.10 DiaSorin

6.10.1 Company overview
6.10.2 DiaSorin Company Snapshot
6.10.3 Operating business segments
6.10.4 Financial performance
6.10.5 Strategic moves and developments
6.10.6 SWOT analysis of DiaSorin

LIST OF FIGURES

FIG. 1  IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)
FIG. 2  IMFPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)
FIG. 3  IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4  TOP FACTORS IMPACTING GLOBAL SYPHILIS TESTING MARKET, 2014-2020
FIG. 5  TOP INVESTMENT POCKETS OF GLOBAL SYPHILIS TESTING MARKET (2014-2020)
FIG. 6  TOP WINING STRATEGIES IN GLOBAL SYPHILIS TESTING MARKET (2011-2014)
FIG. 7  VALUE CHAIN ANALYSIS OF GLOBAL SYPHILIS TESTING MARKET
FIG. 8  SYPHILIS INCIDENCE IN MEXICO  (2009-2013)
FIG. 9  SYPHILIS INCIDENCE RATE IN MEXICO  (2009-2013)
FIG. 10  KEY FINANCIALS OF ROCHE DIAGNOSTICS BY GEOGRAPHY (2014)
FIG. 11  SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 12  KEY FINANCIALS OF BIOMERIEUX BY APPLICATIONS (2013)
FIG. 13  KEY FINANCIALS OF BIOMERIEUX BY GEOGRAPHY (2013)
FIG. 14  SWOT ANALYSIS OF BIOMERIEUX
FIG. 15  KEY FINANCIALS OF HOLOGIC, INC. BY OPERATING SEGMENTS(2012)
FIG. 16  KEY FINANCIALS OF HOLOGIC, INC. BY GEOGRAPHY (2012)
FIG. 17  SWOT ANALYSIS OF HOLOGIC, INC.
FIG. 18  KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY SEGMENT (2013)
FIG. 19  KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY GEOGRAPHY (2013)
FIG. 20  SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 21  KEY FINANCIALS OF CEPHEID INC. BY GEOGRAPHY(2013)
FIG. 22  KEY FINANCIALS OF CEPHEID INC. BY CLINICAL AND NON CLINICAL MARKET(2013)
FIG. 23  SWOT ANALYSIS OF CEPHEID INC.
FIG. 24  KEY FINANCIALS OF DANAHER CORPORATION BY OPERATING (SEGMENT) 2013
FIG. 25  KEY FINANCIALS OF DANAHER CORPORATION BY GEOGRAPHY (2013)
FIG. 26  SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 27  KEY FINANCIALS OF AFFYMETRIX, INC. BY OPERATING SEGMENTS (2013)
FIG. 28  KEY FINANCIALS OF AFFYMETRIX, INC. BY GEOGRAPHY (2013)
FIG. 29  SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 30  KEY FINANCIALS OF ALERE INC. BY THERAPEUTICS (2013)
FIG. 31  KEY FINANCIALS OF ALERE INC. BY GEOGRAPHY (2013)
FIG. 32  SWOT ANALYSIS OF ALERE INC.
FIG. 33  KEY FINANCIALS OF ABBOTT LABORATORIES BY OPERATING SEGMENTS (2013)
FIG. 34  SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 35  KEY FINANCIALS OF DIASORIN BY TECHNOLOGY (2013)
FIG. 36  KEY FINANCIALS OF DIASORIN BY GEOGRAPHY (2013)
FIG. 37  SWOT ANALYSIS OF DIASORIN

LIST OF TABLES

TABLE 1  GLOBAL SYPHILIS TESTING MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 2  GLOBAL SYPHILIS TESTING MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 3  GLOBAL SYPHILIS TESTING MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 4  GLOBAL SYPHILIS TESTING MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 5  GLOBAL SYPHILIS TESTING MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, VALUE ($MILLION), 2020-2025
TABLE 6  GLOBAL SYPHILIS TESTING MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, VOLUME (MILLION), 2020-2025
TABLE 7  SYPHILIS PREVENTIVE SERVICES BY CDC
TABLE 8  GLOBAL SYPHILIS TESTING MARKET VALUE, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 9  GLOBAL SYPHILIS TESTING MARKET VOLUME, BY GEOGRAPHY, 2014-2020 (MILLION)
TABLE 10  GLOBAL SYPHILIS TESTING MARKET BY TYPES, VALUE ($MILLION), 2014-2020
TABLE 11  GLOBAL SYPHILIS TESTING MARKET BY TYPES, VOLUME (MILLION), 2014-2020
TABLE 12  GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020, VALUE ($MILLION)
TABLE 13  GLOBAL SYPHILIS TESTING MARKET, BY GEOGRAPHY, 2014-2020, VOLUME (MILLION)
TABLE 14  NORTH AMERICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 15  NORTH AMERICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 16  U.S. SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 17  MEXICO SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 18  CANADA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 19  EUROPE SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 20  EUROPE SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 21  SPAIN SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 22  GREECE SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 23  BELGIUM SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 24  GERMANY SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 25  MOLDOVA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 26  UNITED KINGDOM SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 27  REST OF EUROPE SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 28  ASIA PACIFIC SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 29  ASIA PACIFIC SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 30  INDIA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 31  CHINA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 32  JAPAN SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 33  AUSTRALIA SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 34  OTHERS ASIA PACIFIC SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 35  LAMEA SYPHILIS TESTING MARKET, VALUE, ($MILLION), 2014-2020
TABLE 36  LAMEA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 37  LATIN AMERICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 38  LATIN AMERICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 39  ARGENTINA SYPHILIS TESTING MARKET , VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 40  MIDDLE EAST SYPHILIS TESTING MARKET, VALUE ($MILLION) AND VOLUME (MILLION), 2014-2020
TABLE 41  AFRICA SYPHILIS TESTING MARKET, VALUE ($MILLION), 2014-2020
TABLE 42  AFRICA SYPHILIS TESTING MARKET, VOLUME (MILLION), 2014-2020
TABLE 43  ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 44  ROCHE DIAGNOSTICS OPERATING SEGMENTS
TABLE 45  BIOMERIEUX COMPANY SNAPSHOT
TABLE 46  BIOMERIEUX OPERATING SEGMENTS
TABLE 47  HOLOGIC, INC. COMPANY SNAPSHOT
TABLE 48  HOLOGIC, INC. OPERATING SEGMENTS
TABLE 49  BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 50  BECTON DICKINSON AND COMPANY OPERATING SEGMENTS
TABLE 51  CEPHIDE INC COMPANY SNAPSHOT
TABLE 52  CEPHEID INC. OPERATING SEGMENTS
TABLE 53  DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 54  DANAHER CORPORATION OPERATING SEGMENTS
TABLE 55  AFFYMETRIX INC. COMPANY SNAPSHOT
TABLE 56  AFFYMETRIX, INC. OPERATING SEGMENTS
TABLE 57  ALERE INC. COMPANY SNAPSHOT
TABLE 58  ALERE INC. OPERATING SEGMENTS
TABLE 59  ABBOTT LABORATORIES COMPANY SNAPSHOT
TABLE 60  ABBOTT LABORATORIES OPERATING SEGMENTS
TABLE 61  DIASORIN COMPANY SNAPSHOT
TABLE 62  DIASORIN OPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Syphilis Testing Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2020

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo